Serum-lipid reducing principles--possibilities for treatment. 2. Classification of hyperlipidemia
Boberg, J.; Gustafson, A.
Lakartidningen 67 Suppl Iv: 40+
1970
ISSN/ISBN: 0023-7205 PMID: 5511951 Document Number: 24236
Document emailed within 1 workday
Related Documents
Hedstrand, H. 1970: Serum-lipid reducing principles--possibilities for treatment. 4. Diet therapy for atherosclerosis Lakartidningen 67: Suppl Iv: 53+Hood, B. 1970: Serum-lipid reducing principles--possibilities for treatment. 8. Diet and drug treatment Lakartidningen 67: Suppl Iv: 89+
Choluj, B.; Votruba, T.; Kormúth, E. 1991: Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atheroslcerosis. Part I: Principles of classification and methods of dyslipoproteinemia determination Acta Universitatis Carolinae. Medica 37(3-4): 91-105
Weintraub, M.; Grosskopf, I.; Rubinstein, A. 1995: Principles of dietary treatment in hyperlipidemia Harefuah 128(9): 556-561
Stratmann, F.W. 1982: What are the possibilities in the treatment of primary hyperlipidemia in diabetes mellitus? Die Medizinische Welt 33(17): 651
Idzior-Waluś, B. 1992: Influence of lovastatin on serum lipids in patients with primary hyperlipidemia and phenotype IIa and IIB. II. Changes of lipid composition of plasma lipoprotein fractions after lovastatin administration Przeglad Lekarski 49(10): 327-333
Sánchez, T.; Contreras-Yáñez, Iú.; Elías-López, D.; Aguilar Salinas, C.A.; Pascual-Ramos, V. 2014: Prevalence of lipid phenotypes, serum lipid behaviour over follow-up and predictors of serum lipid levels in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease-modifying anti-rheumatic drugs Clinical and Experimental Rheumatology 32(4): 509-515
Kaplan, A.V.; Pozhariskiĭ, V.F. 1981: Classification and treatment principles in multiple injury Voenno-Meditsinskii Zhurnal 4: 30-33
Heidrich, H. 1979: Medical treatment of peripheral occlusive arteriopathies. Possibilities, principles and basis Minerva Medica 70(47): 3255-3263
Hald, T.; Nordling, J. 1981: Classification, examination methods and treatment possibilities in urinary incontinence Nordisk Medicin 96(12): 299-303
Smol'ianikov, A.V. 1971: Classification of soft tissue tumors in the light of general data concerning the principles of classification of blastomatous processes Arkhiv Patologii 33(12): 3-16
Hotz, J.; Kark, W. 1992: Non-ulcer dyspepsia syndrome. Classification, diagnostic verification, etiology and possibilities for treatment Medizinische Klinik 87(1): 21-27
Sumino, H.; Murakami, M. 2016: Causes and Abnormal Lipid Laboratory Values of Secondary Hyperlipidemia: Endocrine Disease Rinsho Byori. Japanese Journal of Clinical Pathology 64(5): 513-517
Hutt, V.; Wechsler, J.G.; Klör, H.U.; Ditschuneit, H. 1980: Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs Artery 8(2): 113-119
Thiengwiboonwong, S.; Chongsuwat, R.; Temcharoen, P.; Pandii, W.; Pavadhgul, P. 2013: Efficacy of dietary modification following the National Cholesterol Education Program (NCEP) recommendation on lipid profiles among hyperlipidemia subjects Journal of the Medical Association of Thailand 96(10): 1257-1267
Nishide, T.; Shirai, K.; Shinomiya, M.; Ishikawa, Y.; Murano, S.; Morisaki, N.; Saito, Y.; Yoshida, S.; Sasaki, N. 1989: Serum lipid levels in hypertensive patients during captopril treatment Clinical Therapeutics 11(6): 820-827
Wesołowska, T. 1979: Effects of chronic inhalation intoxication with carbon disulfide on the content of various lipid metabolism indices in the serum, aorta and cardiac muscle in rabbits. II. Lipid phosphorus and phospholipid fractions in the serum, aorta and cardiac muscle Medycyna Pracy 30(5): 323-330
Ottesen, M.; Svensson, B. 1971: Modification of papain by treatment with glutaraldehyde under reducing and non-reducing conditions Comptes-Rendus des Travaux du Laboratoire Carlsberg 38(11): 171-185
Sawada, S.; Yamamoto, A.; Sudo, H.; Yamashita, H. 1979: Heparin-Ca turbidimetric quantitation of the serum lipoprotein fractions in hyperlipidemia Rinsho Byori. Japanese Journal of Clinical Pathology 27(9): 835-838
Rózański, J. 2000: The effect of hyperlipidemia on metabolism, distribution and secretion of lidocaine in patients with primary hyperlipidemia Annales Academiae Medicae Stetinensis 46: 177-187